Literature DB >> 19919981

Reverse epidemiology in systolic and nonsystolic heart failure: cumulative prognostic benefit of classical cardiovascular risk factors.

Gülmisal Güder1, Stefan Frantz, Johann Bauersachs, Bruno Allolio, Christoph Wanner, Michael T Koller, Georg Ertl, Christiane E Angermann, Stefan Störk.   

Abstract

BACKGROUND: Observational studies indicate that classical cardiovascular risk factors as body mass index, total cholesterol, and systolic blood pressure are associated with improved rather than impaired survival in heart failure ("reverse epidemiology"). We estimated the prognostic role of these risk factors in unselected patients with heart failure. METHODS AND
RESULTS: Consecutive subjects with heart failure of any cause and severity were enrolled (n=867), and survivors were followed for a median period of 594 days (25th to 75th percentile, 435 to 840). Mean age was 70+/-13 years, 41% were female, New York Heart Association class distribution I through IV was 15%/29%/41%/15%, and 49% had preserved left ventricular ejection function. At follow-up, 34% of the patients had died. Low levels of any risk factor (ie, body mass index, total cholesterol, and systolic blood pressure in the low tertile) indicated the highest mortality risk. After adjustment for age, sex, New York Heart Association class, and ejection fraction, >/=2 risk factors in the high tertile indicated a relative reduction in mortality risk of 51% (hazard ratio, 0.49; 95% CI, 0.35 to 0.68; P=0.001) compared with subjects with 3 risk factors in the low tertile. Further adjustment for cause of heart failure, relevant comorbidities, medication, and biomarkers attenuated this association only modestly (hazard ratio, 0.63; 95% CI, 0.45 to 0.89; P=0.009).
CONCLUSIONS: In patients with heart failure, mortality risk counterintuitively increased on a cumulative scale with lower levels of body mass index, total cholesterol, and systolic blood pressure, irrespective of the type and severity of heart failure. Future studies need to identify whether risk factor control as presently recommended should be advocated in all patients with heart failure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19919981     DOI: 10.1161/CIRCHEARTFAILURE.108.825059

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  36 in total

1.  Impact of baseline systolic blood pressure on long-term outcomes in patients with advanced chronic systolic heart failure (insights from the BEST trial).

Authors:  Ravi V Desai; Maciej Banach; Mustafa I Ahmed; Marjan Mujib; Inmaculada Aban; Thomas E Love; Michel White; Gregg Fonarow; Prakash Deedwania; Wilbert S Aronow; Ali Ahmed
Journal:  Am J Cardiol       Date:  2010-07-15       Impact factor: 2.778

2.  Association between direct measures of body composition and prognostic factors in chronic heart failure.

Authors:  Antigone Oreopoulos; Justin A Ezekowitz; Finlay A McAlister; Kamyar Kalantar-Zadeh; Gregg C Fonarow; Colleen M Norris; Jeffery A Johnson; Raj S Padwal
Journal:  Mayo Clin Proc       Date:  2010-07       Impact factor: 7.616

Review 3.  Epidemiology and clinical course of heart failure with preserved ejection fraction.

Authors:  Carolyn S P Lam; Erwan Donal; Elisabeth Kraigher-Krainer; Ramachandran S Vasan
Journal:  Eur J Heart Fail       Date:  2010-08-03       Impact factor: 15.534

4.  Prognostic significance of blood pressure response to exercise in patients with systolic heart failure.

Authors:  Manolis S Kallistratos; Leonidas E Poulimenos; Antonios N Pavlidis; Athanasios Dritsas; Ioannis D Laoutaris; Athanasios J Manolis; Dennis V Cokkinos
Journal:  Heart Vessels       Date:  2011-01-26       Impact factor: 2.037

Review 5.  Body mass index in dementia.

Authors:  S García-Ptacek; G Faxén-Irving; P Cermáková; M Eriksdotter; D Religa
Journal:  Eur J Clin Nutr       Date:  2014-10-01       Impact factor: 4.016

6.  Relation between hemoglobin a(1c) and outcomes in heart failure patients with and without diabetes mellitus.

Authors:  G Sofia Tomova; Vani Nimbal; Tamara B Horwich
Journal:  Am J Cardiol       Date:  2012-03-27       Impact factor: 2.778

Review 7.  Functional adiponectin resistance and exercise intolerance in heart failure.

Authors:  An M Van Berendoncks; Viviane M Conraads
Journal:  Curr Heart Fail Rep       Date:  2011-06

Review 8.  Adipose tissue biology and cardiomyopathy: translational implications.

Authors:  Aslan T Turer; Joseph A Hill; Joel K Elmquist; Philipp E Scherer
Journal:  Circ Res       Date:  2012-12-07       Impact factor: 17.367

9.  Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study.

Authors:  Selma F Mohammed; Barry A Borlaug; Véronique L Roger; Sultan A Mirzoyev; Richard J Rodeheffer; Julio A Chirinos; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2012-10-17       Impact factor: 8.790

10.  [Treatment of chronic left ventricular failure].

Authors:  S Brenner; S Störk; C E Angermann
Journal:  Internist (Berl)       Date:  2009-12       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.